# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 10: Amendment of regulation 21 (clinical trials conducted in third countries)

Extent: E+W+S+N.I.

(1) Regulation 21 is amended as follows.
(2) In the heading, for “third countries” substitute “ countries other than the United Kingdom ”.
(3) In paragraph (1), for “a third” substitute “ another ”.

---
Source: https://www.legislation.gov.uk/uksi/2019/744/regulation/10 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.